Overview: Glucose Challenge 75g Pregnancy TestIntroduction: The Glucose Challenge 75g Pregnancy Test measures glucose after a 75g load to screen for gestational diabetes, preventing fetal complications. Following 2023 ACOG guidelines, it uses spectrophotometry for high sensitivity, aiding in pregnancy screening. This test is critical for early detection, management, and improving outcomes in biochemistry for pregnant patients. It is an alternative screening tool for gestational diabetes, often used in specific protocols.
Other Names: GCT 75g Pregnancy Assay, 75g Glucose Challenge Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: The 75g glucose challenge for pregnancy was adopted in the 1990s as an alternative to the 50g GCT. Spectrophotometry advancements improved accuracy in the 2000s.
Purpose: Screens for gestational diabetes, guides further testing, and monitors glucose levels in pregnant patients to prevent fetal complications.
Test Parameters: 1. Glucose (75g Pregnancy)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum after a 75g glucose load (typically 1 or 2 hours). Report symptoms like fatigue or thirst, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, thirst, or history of gestational diabetes. Include pregnancy stage, current medications, and family history of diabetes.
Consent: Written consent required, detailing the tests purpose, screening implications, and potential need for further diagnostic testing.
Procedural Considerations: Uses spectrophotometry to measure glucose levels post-75g load (protocol-specific timing). Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, often used in international protocols.
Factors Affecting Result Accuracy: Non-fasting, improper timing, hemolysis, or medications (e.g., corticosteroids) can affect results. Patient stress may alter glucose levels.
Clinical Significance: Elevated glucose levels suggest a need for confirmatory OGTT to diagnose gestational diabetes. Normal levels may indicate low risk, but clinical correlation is needed.
Specialist Consultation: Consult an obstetrician or endocrinologist for result interpretation and further testing recommendations.
Additional Supporting Tests: 2-hour OGTT, HbA1c, fasting glucose, or ultrasound to confirm gestational diabetes and assess fetal health.
Test Limitations: As a screening test, it may yield false positives. Results require confirmatory testing for accurate diagnosis.
References: ACOG Gestational Diabetes Guidelines, 2023; Obstetrics & Gynecology, Metzger BE, 2022.
